Table 3 shows the various polyphenol sources, kinds, antimicrobial properties, and their mechanisms of action
A systematic review examining studies on BPC-157 and musculoskeletal healing found that the vast majority were preclinical (primarily conducted in rats), with very limited clinical data in humans
Some individuals who are highly sensitive to neuroactive peptides may prefer to begin slightly lower (100150 mcg) for the first few doses to assess tolerance before moving to the full protocol
Absence of early results in a supervised clinical setting is information that leads to protocol adjustment, not continuation without review
To view a copy of this license, visit About this article Cite this article Wong, F., Stokes, J.M., Cervantes, B
ISSN 0261-3077